NAMS position history
The shares of Newamsterdam Pharma (NAMS) that Palo Alto Investors LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q2: 44,359 shares, $1.5M, 0.21% of portfolio, New
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|